Fienberg AA - Search Results

1

Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice.

Hiroi N, Fienberg AA, Haile CN, Alburges M, Hanson GR, Greengard P, Nestler EJ. Hiroi N, et al. Among authors: fienberg aa. Eur J Neurosci. 1999 Mar;11(3):1114-8. doi: 10.1046/j.1460-9568.1999.00570.x. Eur J Neurosci. 1999. PMID: 10103106

2

Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation.

Nishi A, Snyder GL, Fienberg AA, Fisone G, Aperia A, Nairn AC, Greengard P. Nishi A, et al. Among authors: fienberg aa. Eur J Neurosci. 1999 Jul;11(7):2589-92. doi: 10.1046/j.1460-9568.1999.00724.x. Eur J Neurosci. 1999. PMID: 10383649

3

Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac).

Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P. Svenningsson P, et al. Among authors: fienberg aa. Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3182-7. doi: 10.1073/pnas.052712799. Proc Natl Acad Sci U S A. 2002. PMID: 11880651 Free PMC article.

4

Reduction of cocaine place preference in mice lacking the protein phosphatase 1 inhibitors DARPP 32 or Inhibitor 1.

Zachariou V, Benoit-Marand M, Allen PB, Ingrassia P, Fienberg AA, Gonon F, Greengard P, Picciotto MR. Zachariou V, et al. Among authors: fienberg aa. Biol Psychiatry. 2002 Apr 15;51(8):612-20. doi: 10.1016/s0006-3223(01)01318-x. Biol Psychiatry. 2002. PMID: 11955461

5

Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action.

Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ. Zachariou V, et al. Among authors: fienberg aa. Neuropsychopharmacology. 2006 Mar;31(3):555-62. doi: 10.1038/sj.npp.1300832. Neuropsychopharmacology. 2006. PMID: 16123776

6

The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-D-aspartate responses.

Blank T, Nijholt I, Teichert U, Kügler H, Behrsing H, Fienberg A, Greengard P, Spiess J. Blank T, et al. Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14859-64. doi: 10.1073/pnas.94.26.14859. Proc Natl Acad Sci U S A. 1997. PMID: 9405704 Free PMC article.

7

The DARPP-32 knockout mouse.

Fienberg AA, Greengard P. Fienberg AA, et al. Brain Res Brain Res Rev. 2000 Mar;31(2-3):313-9. doi: 10.1016/s0165-0173(99)00047-8. Brain Res Brain Res Rev. 2000. PMID: 10719158 Review. No abstract available.

8

Motivational effects of ethanol in DARPP-32 knock-out mice.

Risinger FO, Freeman PA, Greengard P, Fienberg AA. Risinger FO, et al. Among authors: fienberg aa. J Neurosci. 2001 Jan 1;21(1):340-8. doi: 10.1523/JNEUROSCI.21-01-00340.2001. J Neurosci. 2001. PMID: 11150351 Free PMC article.

9

DARPP-32: regulator of the efficacy of dopaminergic neurotransmission.

Fienberg AA, Hiroi N, Mermelstein PG, Song W, Snyder GL, Nishi A, Cheramy A, O'Callaghan JP, Miller DB, Cole DG, Corbett R, Haile CN, Cooper DC, Onn SP, Grace AA, Ouimet CC, White FJ, Hyman SE, Surmeier DJ, Girault J, Nestler EJ, Greengard P. Fienberg AA, et al. Science. 1998 Aug 7;281(5378):838-42. doi: 10.1126/science.281.5378.838. Science. 1998. PMID: 9694658

10

A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor.

Snyder GL, Fienberg AA, Huganir RL, Greengard P. Snyder GL, et al. Among authors: fienberg aa. J Neurosci. 1998 Dec 15;18(24):10297-303. doi: 10.1523/JNEUROSCI.18-24-10297.1998. J Neurosci. 1998. PMID: 9852567 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

58 results

Search Page

Filters